Related Experiment Video

Updated: May 28, 2026

Generation of Human Chimeric Antigen Receptor Regulatory T Cells
10:29

Generation of Human Chimeric Antigen Receptor Regulatory T Cells

Published on: January 3, 2025

Carbosilane dendrimer 2G-NN16 represses Tc17 differentiation in primary T CD8+ lymphocytes

Rafael Gras1, María I García, Rafael Gómez

  • 1Hospital General Universitario Gregorio Marañón, Doctor Esquerdo 46, 28007-Madrid, Spain.

Molecular Pharmaceutics
|October 26, 2011
PubMed

Insights

The carbosilane dendrimer 2G-NN16 influences gene expression in CD8+ T lymphocytes, potentially aiding gene therapy and treating inflammatory diseases by inhibiting Tc17 cell differentiation.

Area of Science:

  • Immunology
  • Nanomedicine
  • Molecular Biology

Background:

  • Carbosilane dendrimers are investigated for their therapeutic potential.
  • CD8+ T lymphocytes, particularly Tc17 cells, play a role in inflammatory processes.
  • Understanding gene expression changes is crucial for evaluating novel drug candidates.

Purpose of the Study:

  • To assess the impact of the carbosilane dendrimer 2G-NN16 on gene expression in CD8+ T lymphocytes.
  • To evaluate 2G-NN16's potential for gene therapy and as an anti-inflammatory medication.
  • To investigate 2G-NN16's effect on Tc17 cell differentiation.

Main Methods:

  • Global gene expression profiling using microarrays on CD8+ T lymphocytes.
  • Validation of microarray results using real-time quantitative reverse transcriptase polymerase chain reaction (qRT-PCR).
  • In vitro assessment of Tc17 cell differentiation inhibition in the presence of IL6 and TGF-B1.

Main Results:

  • 2G-NN16 induced ribosomal protein expression in CD8+ T lymphocytes.
  • Interleukins IL17A and IL17F, secreted by Tc17 cells, were down-regulated by 2G-NN16.
  • 2G-NN16 demonstrated in vitro inhibition of CD8+ T lymphocyte differentiation into Tc17 cells.

Conclusions:

  • 2G-NN16 modulates gene expression in CD8+ T lymphocytes, including ribosomal proteins and key inflammatory cytokines.
  • The dendrimer shows potential for inhibiting Tc17 cell differentiation, suggesting a therapeutic role in inflammatory conditions.
  • 2G-NN16 may serve as a valuable tool for drug delivery and the management of Tc17-driven inflammatory diseases.

More Related Videos

In Vitro Differentiation of Naive CD4+ T Cells into Pathogenic Th17 Cells in Mouse07:46

In Vitro Differentiation of Naive CD4+ T Cells into Pathogenic Th17 Cells in Mouse

Published on: October 25, 2024

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells10:04

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Published on: August 1, 2025

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...